BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28928865)

  • 1. Refining the American Joint Committee on Cancer Staging Scheme For Resectable Pancreatic Ductal Adenocarcinoma Using Recursive Partitioning Analysis.
    Jiang Y; Su Y; Chen Y; Li Z
    J Cancer; 2017; 8(14):2765-2773. PubMed ID: 28928865
    [No Abstract]   [Full Text] [Related]  

  • 2. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
    Chen YT; Huang ZP; Zhou ZW; He MM
    Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8
    Chen HY; Wang X; Zhang H; Liu XB; Tan CL
    World J Gastroenterol; 2019 Dec; 25(46):6752-6766. PubMed ID: 31857777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis.
    Yuan SQ; Chen YT; Huang ZP
    J Gastrointest Surg; 2017 Oct; 21(10):1591-1598. PubMed ID: 28752402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
    Li HJ; Chen YT; Yuan SQ
    Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Refined Staging Model for Resectable Pancreatic Ductal Adenocarcinoma Incorporating Examined Lymph Nodes, Location of Tumor and Positive Lymph Nodes Ratio.
    Song Y; Chen Z; Chen L; He C; Huang X; Duan F; Wang J; Lao X; Li S
    J Cancer; 2018; 9(19):3507-3514. PubMed ID: 30310507
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis.
    Hu H; Qu C; Tang B; Liu W; Ma Y; Chen Y; Xie X; Zhuang Y; Gao H; Tian X; Yang Y
    Chin J Cancer Res; 2021 Aug; 33(4):457-469. PubMed ID: 34584371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of American Joint Committee on Cancer 8
    Yin F; Saad M; Xie H; Lin J; Jackson CR; Ren B; Lawson C; Karamchandani DM; Bernabeu BQ; Jiang W; Dhir T; Zheng R; Schultz CW; Zhang D; Thomas CL; Zhang X; Lai J; Schild M; Zhang X; Liu X
    World J Gastrointest Pharmacol Ther; 2020 Jun; 11(2):25-39. PubMed ID: 32550043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Grade: A Novel Staging System.
    Ren H; Wu CR; Qiu GT; Zhang LP; Aimaiti S; Wang CF
    J Oncol; 2020; 2020():9093729. PubMed ID: 33014058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Husain ZA; Chen T; Corso CD; Wang Z; Park H; Judson B; Yarbrough W; Deshpande H; Mehra S; Kuo P; Decker RH; Burtness BA
    JAMA Oncol; 2017 Mar; 3(3):358-365. PubMed ID: 27737449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
    van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
    JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer.
    Keane FK; Chen YH; Tishler RB; Schoenfeld JD; Haddad RI; Goguen LA; Catalano P; Neville BA; Margalit DN
    Head Neck; 2016 Oct; 38(10):1530-8. PubMed ID: 27080700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a new staging system for node-negative gastric cancer based on recursive partitioning analysis: An international multi-institutional study.
    Lin JX; Wang ZK; Wang W; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Zhou ZW; Huang CM
    Cancer Med; 2019 Jun; 8(6):2962-2970. PubMed ID: 31070023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the 7 th and 8 th Editions of the American Joint Committee on Cancer Staging System in Patients with Intraductal Papillary Mucinous Neoplasm-Associated PDAC : A Multi-institutional Analysis.
    Margonis GA; Pulvirenti A; Morales-Oyarvide V; Buettner S; Andreatos N; Kamphues C; Beyer K; Wang J; Kreis ME; Cameron JL; Weiss MJ; Soares K; Fernández-Del Castillo C; Allen PJ; Wolfgang CL
    Ann Surg; 2023 Apr; 277(4):681-688. PubMed ID: 34793353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.
    Pu N; Yin L; Habib JR; Gao S; Hu H; Zhu Y; Wu Y; Yu J; Lou W
    Future Oncol; 2019 Oct; 15(30):3457-3465. PubMed ID: 31460788
    [No Abstract]   [Full Text] [Related]  

  • 18. AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN.
    Fan Z; Cheng H; Jin K; Gong Y; Huang Q; Xu J; Ni Q; Yu X; Liu C; Luo G
    World J Surg Oncol; 2019 Aug; 17(1):137. PubMed ID: 31387646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multinational validation of the American Joint Committee on Cancer 8th edition pancreatic cancer staging system in a pancreas head cancer cohort.
    Kwon W; He J; Higuchi R; Son D; Lee SY; Kim J; Kim H; Kim SW; Wolfgang CL; Cameron JL; Yamamoto M; Jang JY
    J Hepatobiliary Pancreat Sci; 2018 Sep; 25(9):418-427. PubMed ID: 30118171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.
    Bilimoria KY; Bentrem DJ; Ko CY; Ritchey J; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Aug; 110(4):738-44. PubMed ID: 17580363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.